[Rheumatoid arthritis: early detection may nip it in the bud]

Ned Tijdschr Geneeskd. 2005 Mar 26;149(13):685-7.
[Article in Dutch]

Abstract

The finding that IgM-rheumatoid factor and anti-cyclic citrullinated peptide were present in stored blood samples in a significant number of patients with rheumatoid arthritis years before the manifestation of the disease, suggests the disease has a long pre-clinical phase. It might thus be possible to prevent clinical disease by initiating treatment in this pre-clinical phase. Recently a Dutch clinical trial was started with this objective. Patients at risk will be randomised to receive dexamethasone or placebo treatment.

Publication types

  • Comment
  • English Abstract

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Arthritis, Rheumatoid / diagnosis*
  • Arthritis, Rheumatoid / prevention & control
  • Autoantibodies / blood*
  • Citrulline / immunology*
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use
  • Humans
  • Immunoglobulin M / blood
  • Netherlands
  • Rheumatoid Factor / blood*
  • Risk Factors
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • Immunoglobulin M
  • Citrulline
  • Dexamethasone
  • Rheumatoid Factor